Home / Generics

Generics

News

Vytorin generic launched in the US posted 26/05/2017

The US Food and Drug Administration (FDA) has approved a generic version of the anti-cholesterol drug Vytorin, which will be...

First Advair generic launched in the US posted 18/05/2017

Teva Pharmaceutical Industries (Teva) has announced the launch of AirDuo RespiClick and its authorized generic, the first com...

Patent challenges hit Actavis and Acorda posted 28/04/2017

Teva Pharmaceuticals’ subsidiary Actavis and neurological drug specialist Acorda Therapeutics have both faced patent challeng...

FDA approves Akorn’s mycophenolate mofetil following Form 483 resolution posted 07/04/2017

US-based generic pharmaceutical manufacturer, Akorn Inc has announced that its sterile manufacturing site in Decatur, Illinoi...

Generic antidepressant launched in the US posted 31/03/2017

US pharma giant Pfizer is facing competition for its antidepressant Pristiq (desvenlafaxine) with generics hitting the market...

 

Research

Generic substitution of antiretroviral drugs in Ireland: patient views posted 26/05/2017

Researchers in Ireland report the findings of a survey of opinions on the generic substitution of antiretroviral (ARV) drugs...

Reference pricing for generics in Switzerland posted 05/05/2017

In 2016, the Swiss Federal Office for Health (FOH) planned to modify the reference pricing scheme for generics. Rather than u...

Approaches to assure quality and improve patient perceptions of generics in Japan posted 02/05/2017

The rapidly ageing population in Japan has led the government to promote the use of generics in the universal health insuranc...

Significant price reductions possible for new cancer drugs posted 21/04/2017

Generic production could drastically reduce the prices of novel cancer drugs and make treatments accessible to thousands more...

Generics could cut costs of cancer drugs by over 99% posted 21/04/2017

Generics manufacturing and import of novel cancer drugs could massively reduce their costs in the UK, according to a study by...

 

General

Generics and biosimilars: status in the EU posted 26/05/2017

According to Medicines for Europe, without generic medicines Europe would have paid Euros 100 billion more for its medicines...

Concerns over change to generics prescribing in Australia posted 19/05/2017

In its 2017 budget, Australia is set to make changes that will encourage the use of generics and that are estimated could sav...

Generics applications under review by EMA – April 2017 posted 19/05/2017

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

Indian drug industry faces setbacks in Europe and the US posted 28/04/2017

The European Medicines Agency (EMA) has announced that they have recommended the suspension of generic drug approvals and dru...

FDA commits to success of the generic and biosimilar second-generation user fee acts posted 21/04/2017

Representatives of the Centre for Drug Evaluation and Research (CDER), the Association of Accessible Medicines (AAM), the Bio...

Generics News Research General

more

Biosimilars News Research General

more